Academic Journal
Q1Journal of Prevention of Alzheimer’s Disease
About Journal of Prevention of Alzheimer’s Disease
Journal of Prevention of Alzheimer's Disease is a scholarly journal published by Elsevier Masson s.r.l.. SCImago 2025 lists it in Q1, with an SJR of 2.269 and H-index of 48.
Coverage: 2014, 2017-2026. Research categories: Neurology (clinical) (Q1); Psychiatry and Mental Health (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Dementia and Cognitive Impairment Research; Alzheimer's disease research and treatments; Nutritional Studies and Diet; Health Systems, Economic Evaluations, Quality of Life; Cancer-related cognitive impairment studies; Health, Environment, Cognitive Aging.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prevalence, risk factors, and racial disparities in probable and possible dementia: the national health and aging trends study
Young-Shin Lee, Juan A. Cruz, Michelle Kabakibi, Alison Moore et al.
2026-12 · DOI: 10.1016/j.tjpad.2026.100676Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features
E. Pinar Coskun, Justin Barber, Lauren Bojarski, Christopher J. McLouth et al.
2026-12 · DOI: 10.1016/j.tjpad.2026.100669Feasibility of immersive 40 Hz gamma sensory stimulation in early-stage Alzheimer’s disease
Carolina Reis, Laura Hainke, Gabriel Headley, Sergi Navarro et al.
2026-12 · DOI: 10.1016/j.tjpad.2026.100679Characterization of a metabolomics signature of the brain-health-promoting MIND diet in older persons
Jeanne Neuffer, Raúl González-Domínguez, Sophie Lefèvre-Arbogast, Dorrain Y Low et al.
2026-12 · DOI: 10.1016/j.tjpad.2026.100670Evoke (+) trials of semaglutide for early alzheimer’s disease: Innovations, lessons, and implications
Jeffrey L. Cummings, Philip Scheltens
2026-12 · DOI: 10.1016/j.tjpad.2026.100677Quantifying generalization error in machine learning prediction of cognitive decline
Roya Melanie Hüppi, Nicolas Langer, Bruno Hebling Vieira
2026-11 · DOI: 10.1016/j.tjpad.2026.100646From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network
Giovanna Zamboni, Manuela Tondelli, Giulia Vinceti, Chiara Gallingani et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100655National Prevalence and Care Needs of Dementia in Adults Aged >=55 Years: Findings from the China Mental Health Survey
Zhaorui Liu, Guangming Xu, Ruoxi Ding, Chao Ma et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100659Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]
Moeko Noguchi-Shinohara, Daiki Muramatsu, Ayano Shima, Yasuhiro Sakashita et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100668Psychological adversities and epigenetic ageing in midlife and older age: A systematic review and meta-analysis
Jiuyu Guo, Jiatong Shan, Kaisy Xinhong Ye, Wei Liang et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100650Comprehensive social determinants of health and brain health in midlife
Christina S. Dintica, Julia Cheunkarndee, R. Nick Bryan, Lenore J. Launer et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100652Oxidation over omega-3: Reinterpreting the paradoxical link between fish oil supplements and accelerated cognitive decline
Dong'e Huang, Munan Lin, Junqing Dong
2026-11 · DOI: 10.1016/j.tjpad.2026.100660Integrating frailty into decision-making for disease-modifying therapies in Alzheimer’s disease: a proposed expert-opinion based approach
Giuseppe Bellelli, Ovidio Brignoli, Marco Canevelli, Antonio Cherubini et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100666The missing improvers: Tau pathology, neuroplasticity, and the case for tau-informed patient selection before amyloid immunotherapy
Eric Dinnerstein
2026-11 · DOI: 10.1016/j.tjpad.2026.100653What's good for the heart is good for the brain? Evidence from a rural cohort on the longitudinal relationship between atherosclerotic cardiovascular disease risk and cognitive decline
Maileen G. Ulep
2026-11 · DOI: 10.1016/j.tjpad.2026.100672Timing of cognitive decline onset and life-course trajectories A pooled longitudinal analysis of 14,389 adults across three cohorts
Jan Sebastian Novotný, Sivan Klil-Drori, Yonas Endale Geda, Ziad Nasreddine et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100649From advice to agency: making brain health actionable and equitable for middle-aged adults with mild neurocognitive disorder
Hermine Lenoir
2026-11 · DOI: 10.1016/j.tjpad.2026.100667Choroid plexus volume in pathology-confirmed Alzheimer's disease
Francis Fernandes, Avyarthana Dey, Andy Ma, Nathan W. Churchill et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100648Do methodological limitations and confounding factors explain the apparent acceleration of cognitive decline in older adults taking omega-3 fatty acid supplements?
Simon C. Dyall, Mélanie Plourde
2026-11 · DOI: 10.1016/j.tjpad.2026.100661Brain health strategies in middle-aged individuals with mild neurocognitive disorder: a scoping review
Joshi Dookhy, Yvonne McCague, Jim Hickson, Diarmuid Stokes et al.
2026-11 · DOI: 10.1016/j.tjpad.2026.100657Reviews
Community Reviews
Version History
September 23, 2026 at 8:52 pm
September 22, 2026